JPM26: Confident Merck Sees Growth Through Keytruda Loss of Exclusivity

Merck CEO Rob Davis expressed high confidence during the company’s J.P. Morgan presentation on Monday, revealing that the company is open to deals in the range of “multi tens of billions of dollars.”